Frustaci, A.; Najafian, B.; Donato, G.; Verardo, R.; Chimenti, C.; Sansone, L.; Belli, M.; Vernucci, E.; Russo, M.A.
Divergent Impact of Enzyme Replacement Therapy on Human Cardiomyocytes and Enterocytes Affected by Fabry Disease: Correlation with Mannose-6-phosphate Receptor Expression. J. Clin. Med. 2022, 11, 1344.
https://doi.org/10.3390/jcm11051344
AMA Style
Frustaci A, Najafian B, Donato G, Verardo R, Chimenti C, Sansone L, Belli M, Vernucci E, Russo MA.
Divergent Impact of Enzyme Replacement Therapy on Human Cardiomyocytes and Enterocytes Affected by Fabry Disease: Correlation with Mannose-6-phosphate Receptor Expression. Journal of Clinical Medicine. 2022; 11(5):1344.
https://doi.org/10.3390/jcm11051344
Chicago/Turabian Style
Frustaci, Andrea, Behzad Najafian, Giuseppe Donato, Romina Verardo, Cristina Chimenti, Luigi Sansone, Manuel Belli, Enza Vernucci, and Matteo Antonio Russo.
2022. "Divergent Impact of Enzyme Replacement Therapy on Human Cardiomyocytes and Enterocytes Affected by Fabry Disease: Correlation with Mannose-6-phosphate Receptor Expression" Journal of Clinical Medicine 11, no. 5: 1344.
https://doi.org/10.3390/jcm11051344
APA Style
Frustaci, A., Najafian, B., Donato, G., Verardo, R., Chimenti, C., Sansone, L., Belli, M., Vernucci, E., & Russo, M. A.
(2022). Divergent Impact of Enzyme Replacement Therapy on Human Cardiomyocytes and Enterocytes Affected by Fabry Disease: Correlation with Mannose-6-phosphate Receptor Expression. Journal of Clinical Medicine, 11(5), 1344.
https://doi.org/10.3390/jcm11051344